Therapeutic Asset Ratings

329 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
s-309309 Obesity Disorder	Shionogi	P2	CCC (53)
TCR .ALPHA..BETA. (RECEPTOR), ANTI-(HUMAN P53 (PROTEIN)) (SYNTHETIC HUMAN SINGLE-CHAIN PRECURSOR) FUSION PROTEIN WITH INTERLEUKIN 2 (HUMAN) Obesity Disorder	Altimmune, Inc.	P2	CCC (53)
Vancomycin Obesity Disorder	Assaf Harofeh MC	P2	CCC (53)
Eplerenone Obesity Disorder	Hippocration General Hospital	P4	CCC (52)
Triticum Aestivum Obesity Disorder	Coordinación de Investigación en Salud, Mexico	P3	CCC (52)
rgt001-075 Obesity Disorder	Regor Pharmaceuticals Inc.	P2	CCC (52)
Diethylpropion Obesity Disorder	Louisiana State University Health Sciences Center in New Orleans	P4	CCC (51)
Lomaira Obesity Disorder	Loma Linda University	P4	CCC (51)
Rosuvastatin Obesity Disorder	Beijing QL Biopharmaceutical Co.,Ltd	P1	CCC (51)
CILASTATIN Obesity Disorder	University of Illinois at Chicago	P4	CCC (50)
Bictegravir Obesity Disorder	José Antonio Mata Marín	P3	CCC (50)
Carboplatin Obesity Disorder	Hacettepe University	P3	CCC (50)
(±)-FTC Obesity Disorder	José Antonio Mata Marín	P3	CCC (50)
Kai-9531 Obesity Disorder	Kailera	P3	CCC (50)
SYNTHETIC LEVOTHYROXINE Obesity Disorder	Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud	P3	CCC (50)
Tenofovir Alafenamide Obesity Disorder	José Antonio Mata Marín	P3	CCC (50)
Zenagamtide Obesity Disorder	Novo Nordisk A/S	P3	CCC (50)
Azithromycin Obesity Disorder	University of Oklahoma	P2	CCC (50)
Clonidine Obesity Disorder	University of Kansas Medical Center	P2	CCC (50)
Dapiglutide Obesity Disorder	Zealand Pharma	P2	CCC (50)
erx1000 Obesity Disorder	ERX Pharmaceuticals	P2	CCC (50)
Garetosmab Obesity Disorder	Regeneron Pharmaceuticals	P2	CCC (50)
immunoglobulin G1-kappa, anti-[Homo sapiens MSTN (myostatin, growth differentiation factor 8, GDF8, GDF-8) latent myostatin complex], humanized monoclonal antibody; Obesity Disorder	Hoffmann-La Roche	P2	CCC (50)
Kai-7535 Obesity Disorder	Kailera	P2	CCC (50)
ro7795081 Obesity Disorder	Hoffmann-La Roche	P2	CCC (50)

Showing 126 to 150 of 329 assets

PreviousPage 6 of 14Next